Asian Journal of Biochemistry, Genetics and Molecular Biology

Apter JT, Shastri K, Pizano K. Update on disease-modifying/preventive therapies in Alzheimer’s disease. Curr Geriatr Rep. 2015;4(4):312-7.

DOI: 10.1007/s13670-015-0141-x, PMID 26543800.

Uwishema O, Mahmoud A, Sun J, Correia IFS, Bejjani N, Alwan M et al. Is Alzheimer’s disease an infectious neurological disease? A review of the literature. Brain Behav. 2022;12(8):e2728. DOI: 10.1002/brb3.2728, PMID 35879909

Lecanu L, Papadopoulos V. Modeling Alzheimer’s disease with non-transgenic rat models. Alzheimers Res Ther. 2013;5(3):17.

DOI: 10.1186/alzrt171, PMID 23634826.

Ali SK, Ali RH. Effects of antidiabetic agents on Alzheimer’s disease biomarkers in experimentally induced hyperglycemic rat model by streptozocin. Plos One. 2022;17(7):e0271138.

DOI: 10.1371/journal.pone.0271138, PMID 35802659

Rygiel K. Novel strategies for Alzheimer’s disease treatment: an overview of anti-amyloid beta monoclonal antibodies. Indian J Pharmacol. 2016;48(6):629-36.

DOI: 10.4103/0253-7613.194867, PMID 28066098

Gasparini L, Netzer WJ, Greengard P, Xu H. Does insulin dysfunction play a role in Alzheimer’s disease? Trends Pharmacol Sci. 2002;23(6):288-93.

DOI: 10.1016/s0165-6147(02)02037-0, PMID 12084635

Knezovic A, Budisa S, Babic Perhoc A, Homolak J, Osmanovic Barilar J. From determining brain insulin resistance in a sporadic Alzheimer’s disease model to exploring the region-dependent effect of intranasal insulin. Mol Neurobiol; 2023.

DOI: 10.1007/s12035-022-03188-5, PMID 36596966

Ferrannini E. The target of metformin in Type 2 diabetes. N Engl J Med. 2014;371(16):1547-8.

DOI:10.1056/NEJMcibr1409796, PMID 25317875.

Malínská H, Oliyarnyk O, Škop V, Šilhavý J, Landa V, Zídek V, et al. Effects of metformin on tissue oxidative and dicarbonyl stress in transgenic spontaneously hypertensive rats expressing human C-reactive protein. Plos One. 2016;11(3):e0150924.

DOI: 10.1371/journal.pone.0150924, PMID 26963617.

Sonnen JA, Larson EB, Brickell K, Crane PK, Woltjer R, Montine TJ et al. Different patterns of cerebral injury in dementia with or without diabetes. Arch Neurol. 2009;66(3):315-22.

DOI: 10.1001/archneurol.2008.579, PMID 19139294

Beeri MS, Schmeidler J, Silverman JM, Gandy S, Wysocki M, Hannigan CM et al. Insulin in combination with other diabetes medication is associated with less Alzheimer neuropathology. Neurology. 2008;71(10):750-7.

DOI:10.1212/01.wnl.0000324925.95210.6d, PMID 18765651

Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. Plos Biol. 2010;8(6):e1000412.

DOI: 10.1371/journal.pbio.1000412, PMID 20613859

Mallikarjuna N, Praveen K, Yellamma K. Role of Lactobacillus plantarum MTCC1325 in membrane-bound transport ATPases system in Alzheimer’s disease-induced rat brain. Bioimpacts. 2016;6(4): 203-9.

DOI:10.15171/bi.2016.27, PMID 28265536

Zhang S, Xu H, Yu X, Wu Y, Sui D. Metformin ameliorates diabetic nephropathy in a rat model of low-dose streptozotocin-induced diabetes. Exp Ther Med. 2017;14(1):383-90.

DOI:10.3892/etm.2017.4475, PMID 28672943

Gasmi S. Classic labyrinth test for neurobehavioral evaluation in Wistar rats. Bio Protoc. 2018;8(18):e3007.

DOI: 10.21769/BioProtoc.3007, PMID 34395798

Radwan AM, Aboelfetoh EF, Kimura T, Mohamed TM, El-Keiy MM. Fenugreek-mediated synthesis of zinc oxide nanoparticles and evaluation of its in vitro and In vivo antitumor potency. Biomed Res Ther. 2021;8(8):4483-96.

DOI: 10.15419/bmrat.v8i8.687.

Tousson E, Beltagy DM, El-Gerbed MSA, Gazia MA, Akela MA. The ameliorating role of folic acid in rat hippocampus after propylthiouracil-induced hypothyroidism. Biomed Aging Pathol. 2012;2(3):104-10.

DOI: 10.1016/j.biomag.2012.07.004

Beltagy DM, Nawar NF, Mohamed TM, Tousson E, El-Keey MM. Beneficial consequences of probiotic on mitochondrial hippocampus in Alzheimer’s disease. J Complement Integr Med. 2021; 18(4):761-7.

DOI:10.1515/jcim-2020-0156, PMID 33781011

Beltagy DM, Nawar NF, Mohamed TM, Tousson E, El-Keey MM. Beneficial consequences of probiotic on mitochondrial hippocampus in Alzheimer’s disease. J Complement Integr Med. 2021;18(4):761-7.

DOI: 10.1515/jcim-2020-0156, PMID 33781011

Burns CM, Chen K, Kaszniak AW, Lee W, Alexander GE, Bandy D et al. Higher serum glucose levels are associated with cerebral hypometabolism in Alzheimer regions. Neurology. 2013;80(17):1557-64.

DOI:10.1212/WNL.0b013e31828f17de, PMID 23535495

Mohamed TM, Youssef MAM, Bakry AA, El-Keiy MM. Alzheimer’s disease improved through the activity of mitochondrial chain complexes and their gene expression in rats by boswellic acid. Metab Brain Dis. 2021;36(2):255-64.

DOI: 10.1007/s11011-020-00639-7, PMID 33159653

Gillani SW, Ghayedi N, Roosta P, Seddigh P, Nasiri O. Effect of metformin on lipid profiles of type 2 diabetes mellitus: A meta-analysis of randomized controlled trials. J Pharm Bioallied Sci. 2021;13(1):76-82.

DOI: 10.4103/jpbs.JPBS_370_20, PMID 34084051

Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zuñiga FA. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol. 2018;17(1):122.

DOI: 10.1186/s12933-018-0762-4, PMID 30170598

Torres LL, Quaglio NB, de Souza GT, Garcia RT, Dati LMM, Moreira WL et al. Peripheral oxidative stress biomarkers in mild cognitive impairment and Alzheimer’s disease. J Alzheimers Dis. 2011;26(1):59-68.

DOI:10.3233/JAD-2011-110284, PMID 21593563

Greilberger J, Koidl C, Greilberger M, Lamprecht M, Schroecksnadel K, Leblhuber F et al. Malondialdehyde, carbonyl proteins and albumin-disulphide as useful oxidative markers in mild cognitive impairment and Alzheimer’s disease. Free Radic Res. 2008;42(7):633-8. doi: 10.1080/10715760802255764, PMID 18654878.

Gustaw‐Rothenberg K, Kowalczuk K, Stryjecka‐Zimmer M. Lipids’ peroxidation markers in Alzheimer’s disease and vascular dementia. Geriatr Gerontol Int. 2010;10(2):161-6.

DOI: 10.1111/j.1447-0594.2009.00571.x, PMID 20446930

Patil SP, Jain PD, Ghumatkar PJ, Tambe R, Sathaye S. Neuroprotective effect of metformin in MPTP-induced Parkinson’s disease in mice. Neuroscience. 2014;277:747-54.

DOI: 10.1016/j.neuroscience.2014.07.046, PMID 25108167

Tang G, Yang H, Chen J, Shi M, Ge L, Ge X et al. Metformin ameliorates sepsis-induced brain injury by inhibiting apoptosis, oxidative stress and neuroinflammation via the PI3K/Akt signaling pathway. Oncotarget. 2017;8(58):97977-89.

DOI: 10.18632/oncotarget.20105, PMID 29228667

Akinola O, Gabriel M, Suleiman A-A, Olorunsogbon F. Treatment of alloxan-induced diabetic rats with metformin or glitazones is associated with amelioration of hyperglycaemia and neuroprotection. TODIAJ. 2012;5(1):8-12.

DOI: 10.2174/1876524601205010008

Sangi SMA, Jalaud NAAl. Prevention and treatment of brain damage in streptozotocin induced diabetic rats with metformin, Nigella sativa, Zingiber officinale, and Punica granatum. Biomed Res Ther. 2019;6(7): 3274-85.

DOI: 10.15419/bmrat.v6i7.554

Pilipenko V, Narbute K, Pupure J, Langrate IK, Muceniece R, Kluša V. Neuroprotective potential of antihyperglycemic drug metformin in streptozocin-induced rat model of sporadic Alzheimer’s disease. Eur J Pharmacol. 2020;881: 173290.

DOI: 10.1016/j.ejphar.2020.173290, PMID 32580040